CIG
NVO

Cairn Investment Group’s Novo Nordisk NVO Stock Holding History

Cairn Investment Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$346K Sell
9,408
-920
-9% -$43.6K 0.17% 51
2025
Q4 		$525K Hold
10,328
– – 0.25% 47
2025
Q3 		$573K Hold
10,328
– – 0.26% 46
2025
Q2 		$713K Buy
10,328
+446
+5% +$30.3K 0.37% 43
2025
Q1 		$686K Sell
9,882
-168
-2% -$13.9K 0.39% 42
2024
Q4 		$865K Sell
10,050
-8,700
-46% -$941K 0.51% 42
2024
Q3 		$2.23M Sell
18,750
-200
-1% -$26.7K 1.23% 26
2024
Q2 		$2.71M Sell
18,950
-200
-1% -$26.5K 1.58% 26
2024
Q1 		$2.46M Sell
19,150
-30
-0.2% -$3.57K 1.41% 24
2023
Q4 		$1.98M Sell
19,180
-50
-0.3% -$4.95K 1.24% 24
2023
Q3 		$1.75M Sell
19,230
-100
-0.5% -$8.81K 1.16% 25
2023
Q2 		$1.56M Sell
19,330
-120
-0.6% -$9.8K 1.01% 27
2023
Q1 		$1.55M Sell
19,450
-17,000
-47% -$1.21M 1.08% 27
2022
Q4 		$2.47M Buy
36,450
+520
+1% +$30.5K 1.84% 18
2022
Q3 		$1.79M Sell
35,930
-1,270
-3% -$68K 1.45% 24
2022
Q2 		$2.07M Sell
37,200
-16,940
-31% -$940K 1.61% 23
2022
Q1 		$3.6M Hold
54,140
– – 2.28% 11
2021
Q4 		$3.03M Sell
54,140
-750
-1% -$40.6K 2.09% 11
2021
Q3 		$2.63M Sell
54,890
-700
-1% -$33.8K 1.95% 11
2021
Q2 		$2.33M Hold
55,590
– – 1.71% 18
2021
Q1 		$1.87M Sell
55,590
-370
-0.7% -$13.2K 1.56% 23
2020
Q4 		$1.95M Sell
55,960
-22,000
-28% -$760K 1.85% 18
2020
Q3 		$2.71M Sell
77,960
-4,290
-5% -$143K 2.87% 5
2020
Q2 		$2.69M Sell
82,250
-3,590
-4% -$115K 3.27% 3
2020
Q1 		$2.58M Buy
85,840
+30
+0% +$893 3.84% 3
2019
Q4 		$2.48M Buy
+85,810
New +$2.38M 2.46% 5

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Cairn Investment Group's NVO Position: Q1 2026 in Review

Cairn Investment Group reduced its Novo Nordisk (NVO) stake by 8.9% in Q1 2026, selling an estimated $43.6K and leaving 9,408 shares worth $346K. The position accounts for 0.17% of the portfolio, ranked #51.

Cairn Investment Group first reported a position in NVO in Q4 2019 and has held it in 26 quarters since. The position peaked at $3.6M in Q1 2022. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Cairn Investment Group held 9,408 shares of Novo Nordisk worth $346K as of Q1 2026.
  • Cairn Investment Group sold 920 Novo Nordisk shares in Q1 2026, an estimated $43.6K.
  • Novo Nordisk made up 0.17% of Cairn Investment Group's portfolio in Q1 2026, its #51 holding.
  • Cairn Investment Group first reported a position in Novo Nordisk in Q4 2019 and has held it in 26 quarters since.
  • Cairn Investment Group's Novo Nordisk position peaked at $3.6M in Q1 2022.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Cairn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.